175 related articles for article (PubMed ID: 3113323)
1. [Gastroduodenal ulcer pathology and prostaglandins].
Bellanger J; Pointereau-Bellanger A
Ann Gastroenterol Hepatol (Paris); 1987 May; 23(3):129-34. PubMed ID: 3113323
[No Abstract] [Full Text] [Related]
2. Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
McColl KE
Dig Dis; 1988; 6(2):65-75. PubMed ID: 3129220
[No Abstract] [Full Text] [Related]
3. Peptic ulcer disease, cytoprotection, and prostaglandins.
Fiske SC
Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
[No Abstract] [Full Text] [Related]
4. Efficacy of prostanoids in the treatment of gastric ulcer.
Rachmilewitz D
Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
[TBL] [Abstract][Full Text] [Related]
5. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins].
Arakawa T; Kobayashi K
Nihon Rinsho; 1988 Jan; 46(1):64-8. PubMed ID: 3131560
[No Abstract] [Full Text] [Related]
6. [Clinical experiences with misoprostol].
Herting RL; Nissen CH
Fortschr Med; 1986 Nov; 104(44):865-8. PubMed ID: 3100408
[No Abstract] [Full Text] [Related]
7. [Current directions in the treatment of gastric and duodenal ulcers].
Fellus R
Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566
[No Abstract] [Full Text] [Related]
8. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
9. A review of the therapeutic efficacy of misoprostol, a prostaglandin E1 analogue.
Nicholson PA
S Afr Med J; 1988 Jul; 74 Suppl():56-8. PubMed ID: 3133797
[No Abstract] [Full Text] [Related]
10. [Enprostil in the acute treatment of duodenal ulcer: direct comparative study with pirenzepin].
Rohner HG; Beckenbach HP; Daake H; Dammann HG; Hüttemann R; Kalek S; Kühn V; Müller P; Simon B
Z Gastroenterol; 1986 May; 24(5):257-61. PubMed ID: 3088860
[TBL] [Abstract][Full Text] [Related]
11. Side effects of anti-ulcer prostaglandins: an overview of the worldwide clinical experience.
Bianchi Porro G; Parente F
Scand J Gastroenterol Suppl; 1989; 164():224-9; discussion 229-31. PubMed ID: 2510273
[TBL] [Abstract][Full Text] [Related]
12. [Therapy and prevention of peptic lesions by prostaglandins].
Müller P; Dammann HG; Simon B
Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin treatment for peptic ulcer.
Walt RP
Scand J Gastroenterol Suppl; 1988; 146():40-9. PubMed ID: 2906468
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandins and peptic ulcer therapy.
Walt RP
Scand J Gastroenterol Suppl; 1990; 174():29-36. PubMed ID: 1976271
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandins for duodenal ulcer.
Lam SK
Clin Invest Med; 1987 May; 10(3):232-7. PubMed ID: 2887323
[TBL] [Abstract][Full Text] [Related]
16. Misoprostol, smoking, and duodenal ulcer healing rates.
Hawkey CJ; Walt RP
Lancet; 1987 Feb; 1(8529):393. PubMed ID: 2880206
[No Abstract] [Full Text] [Related]
17. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
Wilson DE
Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
[TBL] [Abstract][Full Text] [Related]
18. Summary of the 29th meeting of the Gastrointestinal Drugs Advisory Committee, Food and Drug Administration--June 10, 1985.
Lewis JH
Am J Gastroenterol; 1985 Sep; 80(9):743-5. PubMed ID: 3929594
[No Abstract] [Full Text] [Related]
19. [Chronic gastric ulcer in a child with Glanzmann thrombasthenia. Usefulness of prostaglandin E2].
Calva-Rodríguez R; Mejía-Domínguez AM; Pandzich-Arapov S
Bol Med Hosp Infant Mex; 1990 Sep; 47(9):653-5. PubMed ID: 2125426
[TBL] [Abstract][Full Text] [Related]
20. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer].
Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D
Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
